AAAAAA
Results:
1-12
|
Results: 12
Authors:
Cavallo, L
Acquafredda, A
Zecchino, C
De Sanctis, V
Cisternino, M
Nicoletti, MC
Galati, M
Massolo, F
Citation: L. Cavallo et al., Recombinant growth hormone treatment in short patients with thalassemia major: Results after 24 and 36 months, J PED END M, 14(8), 2001, pp. 1133-1137
Authors:
Wasniewska, M
Arrigo, T
Cisternino, M
De Luca, F
Ghizzoni, L
Maghnie, M
Valenzise, M
De Luca, F
Citation: M. Wasniewska et al., Birth weight influences long-term catch-up growth and height prognosis of GH-deficient children treated before the age of 2 years, EUR J ENDOC, 142(5), 2000, pp. 460-465
Authors:
De Sanctis, V
Corrias, A
Rizzo, V
Bertelloni, S
Urso, L
Galluzzi, F
Pasquino, AM
Pozzan, G
Guarneri, MP
Cisternino, M
De Luca, F
Gargantini, L
Pilotta, A
Sposito, M
Tonini, G
Citation: V. De Sanctis et al., Etiology of central precocious puberty in males: The results of the Italian Study Group for Physiopathology of Puberty, J PED END M, 13, 2000, pp. 687-693
Authors:
Cisternino, M
Arrigo, T
Pasquino, AM
Tinelli, C
Antoniazzi, F
Beduschi, L
Bindi, G
Borrelli, P
De Sanctis, V
Farello, G
Galluzzi, F
Gargantini, L
Lo Presti, D
Sposito, M
Tato, L
Citation: M. Cisternino et al., Etiology and age incidence of precocious puberty in girls: A multicentric study, J PED END M, 13, 2000, pp. 695-701
Authors:
Arrigo, T
Cisternino, M
Galluzzi, F
Bertelloni, S
Pasquino, AM
Antoniazzi, F
Borrelli, P
Crisafulli, G
Wasniewska, M
De Luca, F
Citation: T. Arrigo et al., When to stop GnRH analog therapy: The experience of the Italian Study Group for Physiopathology of Puberty, J PED END M, 13, 2000, pp. 759-764
Authors:
Antoniazzi, F
Arrigo, T
Cisternino, M
Galluzzi, F
Bertelloni, S
Pasquino, AM
Borrelli, P
Osio, D
Mengarda, F
De Luca, F
Tato, L
Citation: F. Antoniazzi et al., End results in central precocious puberty with GnRH analog treatment: The data of the Italian Study Group for Physiopathology of Puberty, J PED END M, 13, 2000, pp. 773-780
Authors:
Rizzo, V
De Sanctis, V
Corrias, A
Fortini, M
Galluzzi, F
Bertelloni, S
Guarneri, MP
Pozzan, G
Cisternino, M
Pasquino, AM
Citation: V. Rizzo et al., Factors influencing final/near-final height in 12 boys with central precocious puberty treated with gonadotrophin-releasing hormone agonists, J PED END M, 13, 2000, pp. 781-786
Authors:
Arrigo, T
Cisternino, M
Galluzzi, F
Bertelloni, S
Pasquino, AM
Antoniazzi, F
Borrelli, P
Crisafulli, G
Wasniewska, M
De Luca, F
Citation: T. Arrigo et al., Analysis of the factors affecting anxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precociouspuberty, EUR J ENDOC, 141(2), 1999, pp. 140-144
Authors:
de Sanctis, C
Lala, R
Matarazzo, P
Balsamo, A
Bergamaschi, R
Cappa, M
Cisternino, M
de Sanctis, V
Lucci, M
Franzese, A
Ghizzoni, L
Pasquino, AM
Segni, M
Rigon, F
Saggese, G
Bertelloni, S
Buzi, F
Citation: C. De Sanctis et al., McCune-Albright syndrome: A longitudinal clinical study of 32 patients, J PED END M, 12(6), 1999, pp. 817-826
Authors:
Maghnie, M
Strigazzi, C
Tinelli, C
Autelli, M
Cisternino, M
Loche, S
Severi, F
Citation: M. Maghnie et al., Growth hormone (GH) deficiency (GHD) of childhood onset: Reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults, J CLIN END, 84(4), 1999, pp. 1324-1328
Authors:
Cavallo, L
Gurrado, R
Zecchino, C
Manolo, F
De Sanctis, V
Cisternino, M
Caruso-Nicoletti, M
Galati, M
Citation: L. Cavallo et al., Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency, J PED END M, 11, 1998, pp. 845-849
Authors:
Cisternino, M
Manzoni, SM
Coslovich, E
Autelli, M
Citation: M. Cisternino et al., Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism, J PED END M, 11, 1998, pp. 885-890
Risultati:
1-12
|